Navigation Links
Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod)

Investigational Drug Being Pursued for the Treatment of Ischemic Stroke

GLASGOW, Scotland, May 31, 2007 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI) announced today the presentation of new analysis of data from prior clinical trials of ancrod and updates on the clinical development of their investigational drug, Viprinex (ancrod), for the treatment of acute ischemic stroke at the 16th annual European Stroke Congress in Glasgow, Scotland in the United Kingdom. Viprinex is a defibrinogenating agent derived from the venom of the Malayan pit viper.

"The ancrod data presented this week in Glasgow draws positive conclusions that support a new dosing regimen for ancrod and revised inclusion/exclusion criteria for the current clinical trials," said David Sherman, MD, University of Texas Health Science Center at San Antonio. "The reanalysis enables us to see that ancrod may be safe and effective when administered to patients within six hours of stroke onset. With so few treatments currently available to stroke patients, we look forward to the results of the international phase 3 trials. We hope the phase 3 results provide evidence of definitive safety and efficacy of ancrod in ischemic stroke in the six-hour time window."

    Viprinex(TM)-related sessions at the 2007 European Stroke Congress are:

    -- Poster Session II P 29: Ancrod in a Six Hour Time Window? Evidence For

       and Against Efficacy  by D.G.Sherman University of Texas Health Science

       Center at San Antonio, USA Thursday,  31 May 2007 13:00 to 14:00 GMT

    -- Ongoing Trials Abstract #19: Ancrod Stroke Program (ASP): Two Phase 3

       International, Multi-Center, Randomized, Double-Blind,

       Placebo-Controlled Trials of Ancrod in Acute Ischaemic Stroke by David

       E. Levy, MD (Neurobiological Technologies)

NTI is moving forward with two international, randomized, double-blind, placeb
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
9. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
10. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
11. Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
Post Your Comments:
(Date:9/22/2014)... 2014 ... the addition of the  "Global Freeze Drying ... Market - Forecast to 2019"  report to ... ,The global freeze drying market was valued ... expected to reach at $2,655.9 million by ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s ... of Monday, Sept. 29 at 5 p.m. EDT ... Kids!" competition, in response to continued strong interest ... $50,000 each will be awarded to the winning ... Surgical Innovation Symposium hosted by Children,s National in ...
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014  Continua ... leader in healthcare technology, media and telecommunications,  have ... in China and promote ... and BHG announced this new partnership during the ... in Washington, DC , while ...
Breaking Medicine Technology:Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... 2011 Spectrum Dynamics announced today it has shipped ... Telluride (CZT) nuclear imaging modules from a new supplier, ... of Redlen,s first integrated CZT nuclear imaging detector product ... high resolution, low dose nuclear medicine cameras. ...
... Covidien Plc (COV: $53) has been picked by ... of the Week.  COV carries S&P,s highest investment recommendation ... the largest suppliers in the world of certain medical ... or number-two in businesses representing more than 75% of ...
Cached Medicine Technology:Spectrum Dynamics Announces Shipment of Revolutionary D-SPECT™ Cardiac Imaging Systems Using Redlen's New CZT Nuclear Imaging Modules 2Spectrum Dynamics Announces Shipment of Revolutionary D-SPECT™ Cardiac Imaging Systems Using Redlen's New CZT Nuclear Imaging Modules 3S&P Equity Research Picks COV Focus Stock of the Week 2S&P Equity Research Picks COV Focus Stock of the Week 3S&P Equity Research Picks COV Focus Stock of the Week 4
(Date:9/23/2014)... Ale Gicqueau, President and Chairman at ... for Clinical Trials at the upcoming Pharmaceutical Users ... Friday, September 26, 2014. , PhUSE is an ... PhUSE has expanded from its roots as a conference ... the discussion of topics encompassing the work of data ...
(Date:9/23/2014)... Many people have very limited knowledge and faulty understanding of ... in which a hypnotist induces a trance-like state in a ... suggestion to have them do his bidding, often to entertaining ... aid in managing bad habits like smoking and overeating. But ... can be used. “Hypnosis can facilitate treatment for a wide ...
(Date:9/22/2014)... Petersburg, FL (PRWEB) September 23, 2014 ... of wrinkles. A Sublime Beauty® cream helps to ... botox), boost collagen levels and hydrate beautifully. , ... is a multi-tasker for aging skin," says Kathy ... known as the natural botox, wrinkles are relaxed ...
(Date:9/22/2014)... Utah (PRWEB) September 23, 2014 ... and corporate training, will be attending and exhibiting ... the American Health Information Management Association (AHIMA) in ... September 27 through October 1, and Career Step ... on its suite of coding training products, including ...
(Date:9/22/2014)... 2014 Airbus Helicopters Inc. (AHI) honored ... their efforts to improve safety and quality of service. ... Program of the Year award, both sponsored by AHI, ... Conference Annual Community Awards. , PHI Air Medical ... Charlson Aviation Safety Award, given annually to an individual ...
Breaking Medicine News(10 mins):Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 2Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 3Health News:Hypnosis: What You Don't Know, Dr. Richard Dauber with Morris Psychological Group Dispels Myths and Offers Tips about a Valuable Therapeutic Approach 4Health News:How to Reduce Wrinkles and Improve Aging Skin from Sublime Beauty®; One Day Sale on Now 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3
... to the value of 17.4 billion Norwegian kroners (NOK) were ... 700 kroner per inhabitant. The increase in 2007 was 3.4 ... Drug Statistics maintained by the Norwegian Institute of Public Health. ... in 2007 by 4.9 percent and in 2006 the increase ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... D. Singer, Chief,Executive Officer, is scheduled to present on ... Health Care Conference in Boston, MA. Jeffrey,Taylor, President and ... Event: Deutsche Bank Health Care Conference ...
... Crystal Research Associates, LLC,announced today that it ... Inc. (OTC Bulletin Board: BOCX). The full 52-page,report ... BioCurex, Inc. ("BioCurex" or "the Company") is a ... therapy that target,a global oncology market forecast to ...
... Taxpayers Union Says Extending,Private Coverage for Dialysis Patients ... Care and Generating Taxpayer Savings, WASHINGTON, April ... of patient advocates, dialysis professionals, care,providers and manufacturers ... with kidney disease and kidney failure - applauded ...
... Puzzle ... on the Human Body and Mind, GREENVILLE, N.C. ... Recreation and Leisure Studies today revealed,the results of a ... other mood-lifting effects of so-called "casual",video games. The three ...
... helps pinpoint relationship between Crohn,s disease and colitis , , ... diseases ulcerative colitis and Crohn,s disease appear to share ... studies suggest. , Though similar in many ways, the ... to pinpoint the underlying relationship between them to improve ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3Health News:Kidney Care Community Applauds National Taxpayers Union's Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal 'Common Sense Coverage Reform' 2Health News:Kidney Care Community Applauds National Taxpayers Union's Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal 'Common Sense Coverage Reform' 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... Immuno Concepts manufactures slides that are compatible ... to decrease the number of pipetting steps ... sample dilutions on the slides. Ask Immuno ... and these slides. These slide formats are ...
... patented HEp-2 cell line that has been ... SS-A/Ro autoantibodies, without affecting the other ANA ... published worldwide on the HEp-2000 ANA substrate, ... when used in place of standard HEp-2 ...
... patented HEp-2 cell line that has been ... SS-A/Ro autoantibodies, without affecting the other ANA ... published worldwide on the HEp-2000 ANA substrate, ... when used in place of standard HEp-2 ...
Medicine Products: